Bladder (FISH) Testing
SLP has developed a lab to lab partnership with protocols to screen for hematuria from high risk patient samples to insure timely diagnostics of patients with an increased risk for bladder cancer.
In this process, the lab uses the residual urine specimens collected for toxicology analysis and screens them for hematuria. Presence of blood in the urine triggers urine cytology as well as a Fluorescent In Situ Hybridization (FISH) test for bladder cancer. Evaluation of urine samples indicates that up to 45% of these have hematuria suggestive of a number of conditions including bladder cancer and urinary tract infection. Since pain medication can mask the pain associated with these conditions, many of these patients remain untreated.
Approximately 80% of the cases will normally be over 40 years old and 45% of those cases will have hematuria.
Approximately 1.25% will be positive for bladder cancer ( normal incidence would be 1/5800) and greater 80% will be positive for Urinary Tract Infections.
These tests allow for patients with a positive cytology or FISH test to be referred on for further testing.
To learn more how SLP can help your Bladder (FISH) Testing, call us at 205-661-0001